SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a major beneficiary of the ongoing AI infrastructure supercycle, with investors closely monitoring supply constraints in DRAM and HBM and speculating on potential stock splits. The community is actively debating whether the company's parabolic price action is a fundamental rerating fueled by long-term structural memory demand or an overheated FOMO-driven bubble prone to a sharp correction.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing a massive, AI-driven supercycle that has fueled a parabolic rally, with the community actively debating whether this is a structural re-rating based on memory shortages or an unsustainable, sentiment-fueled bubble. Investors are closely monitoring the stock's extreme momentum and institutional positioning, as discourse remains sharply divided between those calling for a historic crash and those betting on continued gains from the AI infrastructure boom.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

The community is expressing extreme frustration and disbelief as SOXS continues to decline amid a historic, parabolic rally in semiconductor stocks fueled by aggressive AI infrastructure spending and institutional gamma squeezes. Investors are debating the risks of volatility decay and the potential for a massive, systemic reversal, with many cautioning that current sector valuations are detached from fundamentals and driven by speculative mania.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense retail speculation and volatility as traders draw parallels between its MRAM technology and broader semiconductor sector runs. Community conversation is currently polarized, with many investors touting long-term potential for AI and edge computing applications, while others warn of potential pump-and-dump dynamics and pending legal issues.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X (DGXX) is seeing intense investor focus as the market views it as a strategic proxy play for the upcoming Cerebras Systems IPO, driven by a signed long-term contract to build AI data center infrastructure. The community is actively debating the company's growth-focused capital strategyspecifically the increased ATM programwith many retail investors dismissing dilution concerns in favor of the stock's potential to re-rate as a key infrastructure provider in the AI supercycle.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as traders debate its long-term potential and price stability, with the community polarized between those accumulating in anticipation of a parabolic breakout and others voicing frustration over its recent sideways movement. Sentiment is fueled by persistent speculation regarding institutional adoption, upcoming regulatory discussions, and ongoing hopes for renewed interest from high-profile supporters.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is seeing intense investor activity following a revenue beat and a strategic partnership announcement with AMD to build governed enterprise AI infrastructure. While bullish community members are highlighting potential long-term upside and growth in the AI cloud sector, others are expressing significant caution, pointing to the company's substantial debt, past dilution, and the non-binding nature of the AMD memorandum of understanding.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after reporting a positive pre-BLA meeting with the FDA, which solidified the regulatory pathway for sonelokimab in hidradenitis suppurativa and bolstered market confidence in its best-in-class potential. The community is actively discussing the drug's durability and superior profile compared to incumbents, with investors closely watching for the upcoming 52-week clinical data as the primary catalyst for a valuation re-rating.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is drawing significant interest as a primary proxy for pre-IPO exposure to major technology players like SpaceX and Anthropic. The community is actively debating the fund's valuation relative to its holdings, with investors closely watching for catalysts like upcoming IPO filings and management updates that could trigger a re-rating of its net asset value.

Aventus Network

Aventus Network is capturing investor attention as community members highlight its low market capitalization, strategic enterprise partnerships, and integration with the Polkadot ecosystem. Traders are actively monitoring for increased volume and potential exchange listings, viewing the project's recent UAE DAO incorporation and cloud infrastructure expansion as key catalysts for a long-term breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compared to Estimates, MannKind (MNKD) Q1 Earnings: A Look at Key Metrics

The headline numbers for MannKind (MNKD) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

MannKind (MNKD) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

MannKind (MNKD) Reports Q1 Loss, Misses Revenue Estimates

MannKind (MNKD) delivered earnings and revenue surprises of -150.00% and -13.05%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

MannKind (NASDAQ:MNKD) Shares Gap Up - Should You Buy?

MannKind (NASDAQ:MNKD) Shares Gap Up - Should You Buy...

MNKD Stock Records Biggest Single-Day Gains In Over 5 Years, Breaches A Key Technical Milestone – What’s Driving This Rally?

MannKind is developing a dry powder inhalation version of a drug to treat pulmonary arterial hypertension.

Equity

MannKind (MNKD) Expected to Announce Quarterly Earnings on Wednesday

MannKind (NASDAQ:MNKD) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-mannkind-co-stock...

Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of +6.72% and +50.44%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

MannKind (NASDAQ:MNKD) Trading Up 5.5% Following Analyst Upgrade

MannKind (NASDAQ:MNKD) Stock Price Up 5.5% After Analyst Upgrade...

Wells Fargo & Company Boosts MannKind (NASDAQ:MNKD) Price Target to $8.00

Wells Fargo & Company upped their price target on shares of MannKind from $7.00 to $8.00 and gave the company an "overweight" rating in a research report on Tuesday...

HC Wainwright Estimates MannKind's Q1 Earnings (NASDAQ:MNKD)

MannKind Corporation (NASDAQ:MNKD - Free Report) - HC Wainwright lowered their Q1 2026 earnings per share estimates for MannKind in a research note issued on Thursday, April 23rd. HC Wainwright...

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

MNKD
Mannkind Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

MNKDMannkind Corp